Introduction {#Sec1}
============

Genome genetic modification, including gene knockout, gene knockin, and site-directed mutagenesis by replacing target genes with in vitro-modified alleles is an essential tool for studying the genetic basis of bacterial phenotypes at the molecular level \[[@CR4], [@CR17]\]. Current methods are largely based on the principles of allelic exchange using a conventional suicide plasmid, such as pGMB151 \[[@CR8], [@CR11]\]. pGMB151 is a derivative of the suicide plasmid pKNG101 \[[@CR11]\] and includes *oriR6K*, *RP4*, *sacBR*, *insB,* and *strAB* with the *bla* gene from plasmid pBR322 cloned at the *Xba* I site. It is a suicide plasmid because of its requirement for the pir protein, which is supplied by λ*pir* in certain strains of *Escherichia coli*, such as SM10 \[[@CR18]\].

The current suicide plasmid method may not be very efficient because of low recombination rates or illegitimate recombination, so they are often improved \[[@CR12], [@CR17]\]. To improve the efficiency of selecting precise gene-deletion mutants and simplifying the process of genome genetic modification, the *sacB* gene was introduced into a suicide plasmid for a kind of counterselection. The *sacB* gene in the suicide plasmid encodes levansucrase, which hydrolyzes sucrose and glucose to fructose, resulting in the production of a toxic fructan that kills the recombinants containing the suicide plasmid. Thus, sucrose is often used to screen bacteria that have lost the suicide plasmid after a double-crossover event in a single-crossover recombinant. Loss of the suicide plasmid can be easily verified via loss of vector-encoded antibiotic resistance. However, this kind of sucrose counterselection only offers one possibility, and its susceptibility to sucrose is variable in different kinds of gram-negative bacteria: for example, in *Salmonellaenterica*, most single-crossover recombinant bacteria show resistance to sucrose, and a few single-crossover recombinant bacteria are sensitive to sucrose \[[@CR7], [@CR16]\].

Additionally, antibiotic resistance genes have been used to replace the target gene as selectable markers of successful gene deletion \[[@CR8], [@CR14], [@CR15], [@CR17]\]. Although some enzymes may also remove the antibiotic resistance gene, its flanking sequences may not be completely removed. This is an undesirable situation, particularly when precise and scarless--markerless genome genetic modifications are required, such as in genetically engineered attenuated vaccines.

A precise and scarless--markerless genome genetic modification, such as gene knockout for attenuated *Salmonella* vaccines, gene knockin, and site-directed mutagenesis are more difficult without any exogenous nucleotide residuals. The main problem is that double-crossover events following the loss of a suicide plasmid are very difficult to distinguish because of the low frequency of allelic exchange and resistance to sucrose. We believe that a suicide plasmid should have another visual biomarker as a counter selectable tool. Thus, in this study, to improve the efficiency of allelic exchange for genome genetic modification, a novel pGMB152 vector was constructed with the *lacZYA* operon incorporated into pGMB151 to provide *LacZ*-based blue--white selection \[[@CR1]\]. The *LacZ* gene, a well-known reporter gene expressing β-galactosidase, can provide blue--white selection to make the existence of molecular cloning visible \[[@CR2], [@CR6], [@CR13]\] and could be used as a biomarker for the suicide plasmid. Bacteria colonies with pGMB152 will show as blue and those without pGMB152 will show as white; therefore, bacterial colonies with different colors could be distinguished easily during the different processes of genome genetic modification. The new plasmid was used to knock out the *hsdM* gene \[[@CR9]\] in *Salmonellapullorum* to construct a candidate-attenuated *Salmonella* vaccine, to repair pseudogene *flhA* by knockin and pseudogene *flgk* by site-directed mutagenesis.

Materials and Methods {#Sec2}
=====================

Strains, Plasmids, and Media {#Sec3}
----------------------------

The strains and plasmids used in this study are listed in Table [1](#Tab1){ref-type="table"}. Strains were grown routinely in rich liquid or solid Luria Broth media (LB). The media was supplemented with kanamycin (50 μg/mL), ampicillin (100 μg/mL), and streptomycin (25 μg/mL) as required. Solid LB media with 10 % sucrose and without NaCl was used to screen for gene-deletion mutants during the process of allelic exchange.Table 1Strains and plasmids used in this studyMaterialNameUseSourceReferenceBacteria*S.*Pullorum S06004Recipient strainOur laboratory\[[@CR9]\]*E*.*coli*. χ7213Donor strainGift from Dr. R. Curtiss III\[[@CR10]\]*E*.*coli*.spy372For cloningGift from Dr. R. Curtiss III*E*.*coli*. DH5αFor cloningTakara companyPlasmidspGMB151Suicide plasmidOur laboratory\[[@CR11]\]pGMB152Suicide plasmidThis studypFUSETo offer *Lac*ZYA geneOur laboratory\[[@CR1]\]pMD20-TFor cloningTakara company

Construction of Suicide Plasmid pGMB152 {#Sec4}
---------------------------------------

*The lacZYA* cassette was excised from pFUSE (Deng et al. \[[@CR4]\]) using restriction endonucleases *Sam* I and *Sal* I and ligated into pGMB151 digested with the same restriction recognition sites. This novel plasmid was named pGMB152.

Two-Step Scarless--Markerless Knockout of *hsdM* Gene {#Sec5}
-----------------------------------------------------

The chloramphenicol resistance gene (*Cm*^*R*^) from plasmid pKD3, with 54 bp of homologous sequences of the *hsdM* gene flanking the two ends of *Cm*^*R*^, was PCR amplified using primers *hsdM*-*λ*-F/R. This fragment was transformed into *S. pullorum* S06004 to inactivate the *hsdM* gene, with the help of plasmid pKD46 by the λ-red method, to construct *S. Pullorum hsdM::Cm*^*R*^ with an antibiotic marker \[[@CR3]\].

An in vitro-modified allele was constructed into pGMB152. Two DNA fragments (1083-bp *hsdM*12 and 1103-bp *hsdM*34) flanking the *hsdM* gene were amplified by PCR using the primers shown in Table [2](#Tab2){ref-type="table"}. The in vitro-modified allele of *hsdM* 12-34 (Δ*hsdM*) was amplified using splicing by overlapping Extension PCR using primers *hsdM*12-F and *hsdM*34-R, because the primer *hsdM* 34-F was the reverse complement of the primer *hsdM* 12-R \[[@CR5]\]. The amplified fragment was sub-cloned into the *Sal* I site of pMD20-T. A kanamycin-resistant gene cassette (*Km*^*R*^) was inserted at the *Xho* I in the middle of the fragment, with a *Sal* I site at each end \[[@CR3], [@CR8]\]. Subsequently, the DNA fragment between the two *Sal* I sites in the plasmid pMD20T-Δ*hsdM* was introduced into the *Sal* I cloning site of suicide plasmid pGMB152 to construct recombinant suicide plasmid pGMB152-Δ*hsdM*.Table 2Primers used in this study (enzyme sites are shown in lower case)Fragments amplifiedPrimersPrimer sequences (5′-3′)Amplicon size (bp)Note*hsdM*-*λhsdM*-*λ*CTGCTGACCGAAATGCTCGAACC\
GTTCCAGGGCAAAATTTATGACC\
CCTGCTGCtgtgtaggctggagctgcttcg*hsdM*-*λ*TCGGCTTCGCCGCTGGTGTTGGA\
GCTCATCGAGCCGTTCGCCAGCA\
CAAAACCGcatatgaatatcctccttag*hsdM*12*hsdM*12-FaagtcgacctcgagATGCGGGTTCGGTTT\
GTTTG1083*Sal* I, *Xho* I*hsdM*12-RTTCCTGATTGAGTTCATCATGGCC\
TGAAAAGACAATCCCACTCAATG*hsdM*34*hsdM*34-FCATTGAGTGGGATTGTCTTTTCAG\
GCCATGATGAACTCAATCAGGAA1103*Sal* I*hsdM*34-RaagtcgacTGGTCCGAGCCGGATAAATGΔ*hsdM*-YZΔ*hsdM*-YZ-FTGACCACCACCAATGCTACC1920 (wt) 301 (Δ)Δ*hsdM*-YZ-RGTGGAACTGCTGGATGTGGA*flhA*-*λflhA*-*λ*-FCCTTTAATATTGCGCTATCGATCATG\
GTGCTGCTGGTGGCGATGTTTACCC\
AGAtgtgtaggctggagctgcttcg*flhA*-*λ*-RCCAGCGCCGGGATCTGGGCGACCAG\
GCCGTCGCCAATGGTCAGCAGGGTG\
TAGCcatatgaatatcctccttag*flhA*(P125109)*flhA*-FAAgtcgac ctcgag CGGTAAGTCGCTACAGCCAA2349*Sal* I, *Xho* I*flhA*-RAAgtcgac agatct CCTGAG\
ACACGATCCAAC*Sal* IflgK-*λ*flgK-*λ*-FTATTCTGGCGCAGGCAAACAGT\
ACGTTAGGGGCTGGCGGCTGGA\
TAGGTAATGGtgtgtaggctggagctgcttcgflgK-*λ*-RTGCGCCACGCTGGAGCCAATCGCGA\
TATTGACCTGTTTATCCTGATCGCGC\
AGAcatatgaatatcctccttag*flgK*(P125109)*flgK*-FAAcccggg CTCGAGGCTGAA\
AAGTATGCGCGAGG2240*Sma* I, *Xho* I*flgK*-Rcccggg AAGTTATCGCTGTCG\
CCGGTAT*Sma* I

Blue--White Selection for White Double-Crossover from Blue Single-Crossover Bacteria {#Sec6}
------------------------------------------------------------------------------------

Following a previous protocol \[[@CR8]\], the plasmid pGMB152-Δ*hsdM* was electroporated into *E. coli* χ7213, which is diaminopimelic acid (DAP) dependent and kanamycin resistant. Blue colonies were selected on LB agar with 40 μg/ml X-gal, 1 % DAP, and three antibiotics (kanamycin, ampicillin, and streptomycin). Conjugation was then carried out between a donor of blue *E. coli* χ7213 (pGMB152-Δ*hsdM*) and a recipient of *S.* Pullorum *hsdM::Cm*^*R*^. Equal volumes of 24-h LB cultures from the donor and recipient were mixed and spotted immediately onto a nylon filter on an LB plate \[[@CR8], [@CR9]\]. After 36 h of conjugation at 37 °C, the filter was washed with 10 mM MgSO~4~ and the bacteria were plated onto LB plates containing X-gal and the three antibiotics (kanamycin, ampicillin, and streptomycin). The blue colonies presumably resulted from a single-crossover event where the suicide plasmid pGMB152 was integrated into the chromosome at *hsdM*. A random single colony was purified and sub-cultured 4--5 times in liquid LB with 10 % sucrose and without NaCl \[[@CR7], [@CR16]\]. Bacteria were then plated onto LB agar plates and screened for white colonies without chloramphenicol resistance to confirm the presence of plasmid excised double-crossover events. All white colonies were detected again with chloramphenicol selection: the double-crossover deletants should be susceptible to chloramphenicol because *Cm*^*R*^ gene was replaced by in vitro-modified allele.

Confirmation of Deletants by PCR {#Sec7}
--------------------------------

The chromosomal duplication was segregated by homologous recombination between the flanking direct repeats, ultimately leaving one copy of the gene on the chromosome: either the wild-type copy or the deletant copy, and the suicide plasmid pGMB152 were lost simultaneously. The white colonies were further identified by PCR using primers Δ*hsdM*-YZ-F and Δ*hsdM*-YZ-R to distinguish the deletants from the wild-type bacteria.

Two-Step Knockin of the *flhA* and Site-Directed Mutagenesis of *flgk* {#Sec8}
----------------------------------------------------------------------

Following the process of scarless--markerless knockout of *hsdM* gene, all primers were in the Table [2](#Tab2){ref-type="table"}. The λ-red method was used to respectively insert the *Cm*^*R*^ gene into pseudogene *flhA* in which 23 bp from 601 to 623 was lost, using primers *flhA*-*λ*-F/R, and into the *flgK* gene in which a nucleotide [G]{.ul}AA at 373 was changed to [T]{.ul}AA to make a termination codon, using primers *flgK*-*λ*-F/R in *S*. *pullorum*. We then cloned a real gene from *S. enteritidis* P125109 to replace the pseudogene in *S. pullorum* to construct an in vitro-modified allele. Using the blue/white screen strategy in addition to counter selection screening (*sacB* gene), the mutants with a knocked-in *flhA* gene and mutated *flgk* gene were screened. The two genes were amplified by PCR and sequenced for further confirmation.

Results and Discussion {#Sec9}
======================

After construction of the recombinant suicide plasmid pGMB152-Δ*hsdM/Km*^*R*^ and conjugation, only *S. pullorum hsdM::Cm*^*R*^ pGMB152-Δ*hsdM/Km*^*R*^ grew as single-crossover recombinants on LB plates with the antibiotics (chloramphenicol, streptomycin, ampicillin, kanamycin) and without DAP, all colonies were blue (Fig. [1](#Fig1){ref-type="fig"} left-hand panel).Fig. 1Construction of an in vitro-modified allele

When blue *S. pullorum hsdM::Cm*^*R*^ pGMB152-Δ*hsdM/Km*^*R*^ was sub-cultured in liquid media with sucrose and without NaCl, a few bacteria turned white, indicating that plasmid excision double-crossover had occurred (Fig. [1](#Fig1){ref-type="fig"} right-hand panel).

The theoretical probability of finding deletants among the white colonies would be 50 %, because the two gene arms have an identical chance to exchange with the homologous sequence in the target genome. Approximately 10 % of all white colonies were found to be deletants based on incomplete statistics. White deletants were confirmed by PCR with Δ*hsdM*-YZ primers based on their amplicon size and antibiotic resistances; wild-type colonies were excluded (Fig. [2](#Fig2){ref-type="fig"}). The amplicon size should be 301 bp for the white deletants, 1920 bp for white wild-type strain, and both 1920 bp and 301 bp for the blue clones as a control. The amplicon sizes were consistent with the expected results.Fig. 2Blue--white selection. *Left-hand panel* shows *blue* colonies resulting from a single-crossover event, and the *right-hand panel* shows the white colonies (possible *hsdM* deletants) from a double-crossover event (example of *hsdM*) (Color figure online)

Gene knockin and site-directed mutagenesis might be more difficult than gene knockout. We believed that improved plasmid could also be applied successfully for scarless--markerless gene knockin to repair the *flhB* and *flgK* pseudogenes in *S.pullorum*, following the process summarized in Fig. [3](#Fig3){ref-type="fig"}. After repair, the two genes, *flhA* and *flgK*, were amplified and sequenced for further confirmation. The results showed that the original pseudogenes were replaced by real genes. We successfully generated the knockin of the real *flhA* gene using 23 bp from 601 to 623 and performed site-directed mutagenesis of *flgK* to change nucleotide 373 from [T]{.ul}AA, which is a termination codon, to [G]{.ul}AA in S. *pullorum* (Fig. [4](#Fig4){ref-type="fig"}).Fig. 3PCR identification of *hsdM* deletants from *white* colonies. M: DNA Marker DL2000; lane1: S06004 as a control; lane2: White colony 1(wild type S06004); lane3: White colony 2 (S06004Δ*hsdM*); lane4: Blue colony(S06004(pGMB152-Δ*hsdM*)).Fig. 4The process of two-step scarless--markerless genome genetic modification based on suicide plasmid pGMB152

In this study, we found that sucrose-counter selection was relatively inefficient, as indicated by the presence of large numbers of blue colonies among the transformants (Fig. [1](#Fig1){ref-type="fig"} right-hand panel) in *S.pullorum*, possibly because of host adaptation. This further confirmed that double-crossover events occurred rarely in bacteria following the traditional method \[[@CR7], [@CR16]\]. The results indicated that we could select random single-crossover recombinant bacteria without needing to reassess their sucrose sensitivity \[[@CR8]\].

The larger size of vector pGMB152 might make molecular manipulations more difficult. To overcome this problem, an antibiotic resistance gene was cloned in one flank of the in vitro-modified allele for easy selection of recombinants, such as the kanamycin resistance gene in this study (Fig. [1](#Fig1){ref-type="fig"}).

This study is the first report of a suicide plasmid comprising the complete *lacZ* gene that allows visual selection of double-crossover mutants. Although pGMB152 had only one modification, i.e., the entire *lacZYA* operon, compared with pGMB151, it was more efficient and less time consuming in producing allelic exchanges of gram-negative bacteria because of its color discrimination. Thus, the improved suicide plasmid, pGMB152, will be helpful for precise and scarless--markerless genome genetic modification.
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